Assessment of Carotid Artery Stenosis and Lower Limb Peripheral Ischemia Prior to CABG

May 22, 2020 updated by: Mr Ihab Ali

Non-selective Assessment of Carotid Artery Stenosis and Lower Limb Peripheral Ischemia Prior to Coronary Artery Bypass Surgery

From our experience among Egyptian population in our institution, there is an increased prevalence of hidden subclinical peripheral artery disease along with carotid artery affection. Thus, increasing the risk of post-operative morbid complications.We aim to evaluate routine/ non-selective carotid and peripheral arterial screening in asymptomatic patients undergoing coronary artery bypass grafting in the Egyptian populationIt is a prospective, non-randomized, comparative study including two groups of patients. The study will start from the day of approval of the ethical committee. It will include 260 patients, on basis of "all new comers". Patients will be examined and classified as "high-risk" group (ɳ = 130) or "low-risk" group (ɳ=130).

All patients will have the "routine" preoperative investigations along with evaluation of extracranial carotid system by non-invasive carotid duplex and lower limb arterial system by non-invasive bilateral lower limb arterial duplex.

Study Overview

Study Type

Interventional

Enrollment (Actual)

360

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Cardio-thoracic Academy -Ain-Shams University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. The acceptance of the patients to participate in the study in the form of a written consent.
  2. Patients of both sexes.
  3. Three vessels disease for CABG.
  4. Patients' age: from 35 to 75 years old.
  5. Elective, isolated, primary cases of CABG.
  6. Patients with ejection fraction above 40%.
  7. Inclusion criteria for the high-risk group will include:

    1. Patients with preoperative history of cerebrovascular events or symptoms suggestive of CVS eg.TIA, transient blindness in one eye, Dizziness, Confusion, Drowsiness, Headache, Temporary inability to speak or move.
    2. Carotid bruit
    3. Left main stem coronary artery disease
    4. Presence of other peripheral vascular disease

Exclusion Criteria:

  1. Patients refusing to participate in the study.
  2. Age 76 years or above
  3. Morbid obese patients (body mass index more than 35).
  4. Patients who underwent coronary stenting before.
  5. Patients who underwent previous cardiac operation before.
  6. Patients with impaired renal functions (serum creatinine > 1.5 mg/dl, blood urea > 100 mg/dl and K+ > 5 meq/L).
  7. Patients with preoperative hemoglobin < 9 gm/dl, white blood cells > 15,000 cells/mcl,platelets count < 140,000 per microliter.
  8. Patients with rhythm defects by electrocardiography (ECG).
  9. Patients with preoperative O2 saturation < 90 % by pulse oximetry.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: high risk group
history of stroke or TIA, carotid bruit, left main stem disease, other peripheral vascular disease
assessment of carotid stenosis and lower limb peripheral ischemia.
Sham Comparator: low risk group
No history or stroke,TIA. NO left main stem disease
assessment of carotid stenosis and lower limb peripheral ischemia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
culprit pathology in carotid and / or lower limb duplex
Time Frame: 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
new cerebrovascular event or lower limb ischemia in the post operative period
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 5, 2018

Primary Completion (Actual)

April 25, 2020

Study Completion (Actual)

May 10, 2020

Study Registration Dates

First Submitted

April 24, 2018

First Submitted That Met QC Criteria

April 24, 2018

First Posted (Actual)

May 7, 2018

Study Record Updates

Last Update Posted (Actual)

May 26, 2020

Last Update Submitted That Met QC Criteria

May 22, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carotid Artery Diseases

Clinical Trials on carotid duplex, both LL arterial duplex

3
Subscribe